Literature DB >> 13449241

Some properties of an esterase derived from preparations of the first component of complement.

O D RATNOFF, I H LEPOW.   

Abstract

Studies on an esterase derived from partially purified preparations of the first component of complement are described. The esterase hydrolyzed certain synthetic amino acid esters, among which N-acetyl-L-tyrosine ethyl ester was most susceptible. This was hydrolyzed maximally between pH 7.5 and 8.2, and at 41 degrees C. The esterase could not be identified with other previously described hydrolytic enzymes. An esterase with similar properties could also be eluted from antigen-antibody aggregates which had been treated with serum. Human serum contained a heat-labile inhibitor of the esterase which could not be identified with any of the known components of complement. The esterase was also inhibited by certain reducing agents. The experiments described support the early hypothesis that complement exerts its action enzymatically, but the physiological role of the esterase derived from preparations of complement is not yet clear.

Entities:  

Keywords:  COMPLEMENT; ESTERASES

Mesh:

Substances:

Year:  1957        PMID: 13449241      PMCID: PMC2136749          DOI: 10.1084/jem.106.2.327

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Inhibition of immune hemolysis by diisopropyl fluorophosphate.

Authors:  L LEVINE
Journal:  Biochim Biophys Acta       Date:  1955-10

2.  Observations on a pro-esterase associated with partially purified first component of human complement (C'1).

Authors:  I H LEPOW; O D RATNOFF; F S ROSEN; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

3.  Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.

Authors:  I H LEPOW; L WURZ; O D RATNOFF; L PILLEMER
Journal:  J Immunol       Date:  1954-09       Impact factor: 5.422

4.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

5.  The action of plasmin on synthetic substrates.

Authors:  W TROLL; S SHERRY; J WACHMAN
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

6.  Importance of the disulfide (-S-S-) linkage in the blood-clotting mechanism.

Authors:  J R CARTER; E D WARNER
Journal:  Am J Physiol       Date:  1953-04

7.  A modified method for the viscosimetric assay of hyaluronidase.

Authors:  G I Swyer; C W Emmens
Journal:  Biochem J       Date:  1947       Impact factor: 3.857

8.  The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application.

Authors:  S HESTRIN
Journal:  J Biol Chem       Date:  1949-08       Impact factor: 5.157

9.  THE MECHANISM OF ANAPHYLACTIC SHOCK : STUDIES ON FERMENT ACTION. XXIII.

Authors:  J W Jobling; W Petersen; A A Eggstein
Journal:  J Exp Med       Date:  1915-10-01       Impact factor: 14.307

10.  A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS.

Authors:  O G Bier; G Leyton; M M Mayer; M Heidelberger
Journal:  J Exp Med       Date:  1945-05-01       Impact factor: 14.307

View more
  52 in total

1.  BIOLOGIC PROPERTIES OF POLYNUCLEOTIDES. IV. STUDIES ON THE MECHANISM OF COMPLEMENT INHIBITION BY POLYINOSINIC ACID TOGETHER WITH OBSERVATIONS ON THE IN VIVO EFFECT OF POLYINOSINIC ACID ON COMPLEMENT ACTIVITY.

Authors:  S YACHNIN; D ROSENBLUM
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.

Authors:  V H DONALDSON; F S ROSEN
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

3.  [Methodological and clinical studies on the properdin system. III. Studies on the behavior of 4 complement components after major gynecological operations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

4.  Studies on the activation of a serum esterase with ether and its relationship to C'l-esterase.

Authors:  V H DONALDSON
Journal:  J Clin Invest       Date:  1961-04       Impact factor: 14.808

5.  Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

Authors:  O D RATNOFF; E W DAVIE; D L MALLETT
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

6.  The differentiation of the chloroform, peptone and antigen-antibody inducible esterase activities of human serum from plasmin.

Authors:  K F AUSTEN
Journal:  Immunology       Date:  1960-04       Impact factor: 7.397

7.  TAMe esterase activity of guinea-pig serum. II. Peptone inducible esterases.

Authors:  E L BECKER; K F AUSTEN; D M MARCUS
Journal:  Br J Exp Pathol       Date:  1959-10

8.  Kinin formation and fibrinolysis in human plasma.

Authors:  V Eisen
Journal:  J Physiol       Date:  1963-05       Impact factor: 5.182

9.  Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.

Authors:  M H Prandini; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

10.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.